Browse Category

NASDAQ:RANI News 31 October 2025 - 28 November 2025

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) is finishing November with quieter headlines but still very lively trading. As of today, 28 November 2025, the biotech micro‑cap is consolidating after its spectacular October surge on the back of a transformative collaboration with Japan’s Chugai Pharmaceutical and a $60.3 million private placement that extended its cash runway into 2028. Reuters+2Stock Titan+2 Crucially for anyone looking for “RANI stock news today”: Below is a detailed, Google News–friendly breakdown of where RANI stands today, what’s driving sentiment, and what to watch next. RANI stock price on 28 November 2025 Across major data providers, RANI
28 November 2025
RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts

RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts

Updated: November 19, 2025 Rani Therapeutics Holdings (NASDAQ: RANI) finished Wednesday, Nov. 19, 2025 at $1.75, down from $1.86 on Tuesday. The stock opened at $1.83, traded between $1.70–$1.90, and moved ~2.5M shares on the day, according to end‑of‑day pricing data. Yahoo Finance Today’s trading at a glance (19.11.2025) Was there fresh company news today?As of publication on Nov. 19, no new Rani press releases or material company updates were posted today. The most recent company news remains the Q3 2025 results issued Nov. 6. Rani Therapeutics, LLCLikewise, no new SEC filings were posted today; the latest notable filing was
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Rockets 51% on Obesity Pill Breakthrough and $1B Pharma Deal

Stock Price and Recent Performance RANI has seen explosive moves this month. As of the Oct 31 close, Rani Therapeutics stock was $2.20 (up $0.75, +51.7%)stockanalysis.com. This follows a monumental rally: on Oct 17, RANI nearly tripled from ~$0.47 to an intraday high of $2.39 (+248%)ts2.techstockanalysis.com after the company announced the Chugai collaboration and financing. Even after that spike, RANI remained volatile – it spent mid-October around $1.50–2.50, briefly crossing Nasdaq’s $1 bid threshold and greatly lifting its market cap. Volume has been extremely high: for example, ~172 million shares traded on Oct 20 and ~124 million on Oct 21stockanalysis.com, versus an average of only

Stock Market Today

National Grid share price on a six-session run: what could move NG.L when London reopens

National Grid share price on a six-session run: what could move NG.L when London reopens

8 February 2026
National Grid closed Friday at 1,285 pence, up 0.23%, marking its sixth straight gain and trading near a 52-week high. Investors focused on Bank of England survey results showing expectations for Bank Rate to fall to 3.0% by March 2027. UK GDP, trade, and industrial output data are due Feb. 12. 6.51 million National Grid shares changed hands in the session.
Idox share price stuck below 71.5p bid as Long Path says backing nears control

Idox share price stuck below 71.5p bid as Long Path says backing nears control

8 February 2026
Long Path Partners said it has aggregate support for about 49.26% of Idox shares for its 71.5p-per-share cash offer. Idox shares closed Friday at 71.0p, about 0.7% below the offer price. Valid acceptances stood at 19.12% as of Feb. 5, with the offer open until March 16. The deal requires more than 50% of voting rights to go unconditional.
BAE Systems share price: Buyback update and Launchpad incubator set up Feb 18 results

BAE Systems share price: Buyback update and Launchpad incubator set up Feb 18 results

8 February 2026
BAE Systems shares closed up 1.2% at 1,879 pence on Friday, with 5.6 million shares traded. The company disclosed buying back 115,039 shares for cancellation at a volume-weighted average price of 1,860.32 pence. Over 1,200 BAE workers in northwest England are striking over pay until at least Feb. 20. Full-year results are due Feb. 18.
Go toTop